<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0465-546X</journal-id>
<journal-title><![CDATA[Medicina y Seguridad del Trabajo]]></journal-title>
<abbrev-journal-title><![CDATA[Med. segur. trab.]]></abbrev-journal-title>
<issn>0465-546X</issn>
<publisher>
<publisher-name><![CDATA[Escuela Nacional de Medicina del Trabajo. Instituto de Salud Carlos III]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0465-546X2021000100006</article-id>
<article-id pub-id-type="doi">10.4321/s0465-546x2021000100001</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Medicamentos peligrosos]]></article-title>
<article-title xml:lang="en"><![CDATA[Hazardous drugs]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García Salom]]></surname>
<given-names><![CDATA[Pedro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital General Universitario Servicio de Farmacia ]]></institution>
<addr-line><![CDATA[Alicante ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2021</year>
</pub-date>
<volume>67</volume>
<numero>262</numero>
<fpage>6</fpage>
<lpage>10</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S0465-546X2021000100006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S0465-546X2021000100006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S0465-546X2021000100006&amp;lng=en&amp;nrm=iso"></self-uri></article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goodman]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Wintrobe]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Dameshek]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Goodman]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Gilman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[McLennan]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders]]></article-title>
<source><![CDATA[J Am Med Assoc]]></source>
<year>1946</year>
<volume>132</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>126-32</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<collab>Society of Hospital Pharmacists of Australia</collab>
<article-title xml:lang=""><![CDATA[Guidelines for safe handling of cytotoxic drugs in pharmacy departments and hospital wards]]></article-title>
<source><![CDATA[Hosp Pharm]]></source>
<year>1981</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>17-20</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<collab>American Society of Hospital Pharmacists</collab>
<article-title xml:lang=""><![CDATA[ASHP technical assistance bulletin on handling cytotoxic drugs in hospitals]]></article-title>
<source><![CDATA[Am J Hosp Pharm]]></source>
<year>1985</year>
<volume>42</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>131-7</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<collab>American Society of Hospital Pharmacists</collab>
<article-title xml:lang=""><![CDATA[ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs]]></article-title>
<source><![CDATA[Am J Hosp Pharm]]></source>
<year>1990</year>
<volume>47</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1033-49</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Burroughs]]></surname>
<given-names><![CDATA[GE]]></given-names>
</name>
<name>
<surname><![CDATA[Connor]]></surname>
<given-names><![CDATA[TH]]></given-names>
</name>
<name>
<surname><![CDATA[McDiarmid]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Mead]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
<name>
<surname><![CDATA[Power]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Reed]]></surname>
<given-names><![CDATA[LD]]></given-names>
</name>
</person-group>
<source><![CDATA[NIOSH Alert: preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings]]></source>
<year>2004</year>
<publisher-loc><![CDATA[Atlanta, USA ]]></publisher-loc>
<publisher-name><![CDATA[National Institute of Occupational Safety and Health(NIOSH), Department of Health and Human Services, Center for Disease Control and Prevention]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Connor]]></surname>
<given-names><![CDATA[TH]]></given-names>
</name>
<name>
<surname><![CDATA[MacKenzie]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[DeBord]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Trout]]></surname>
<given-names><![CDATA[DB]]></given-names>
</name>
</person-group>
<collab>O'Callaghan JP</collab>
<source><![CDATA[NIOSH List of antineoplastic and other hazardous drugs in healthcare settings, 2014]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Atlanta, USA ]]></publisher-loc>
<publisher-name><![CDATA[National Institute of Occupational Safety and Health(NIOSH), Department of Health and Human Services, Center for Disease Control and Prevention]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Erce]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Preventing occupational exposure to cytotoxic and other hazardous drugs: European Policy Recommendations]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Brussels, Belgium ]]></publisher-loc>
<publisher-name><![CDATA[Rodhe Public Policy]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Braun]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Riehle]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Donofrio]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Hazif]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Loeb]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<source><![CDATA[Improving patient and worker safety: Opportunities for synergy, collaboration and innovation]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Oakbrook Terrace, Illinois USA ]]></publisher-loc>
<publisher-name><![CDATA[The Joint Commission]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<collab>Occupational and Safety and Health Administration</collab>
<source><![CDATA[Controlling Occupational Exposure to Hazardous Drugs]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Washington DC, USA ]]></publisher-loc>
<publisher-name><![CDATA[OSHA, Department of Labor]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<collab>Pan American Health Organization - World Health Organization</collab>
<source><![CDATA[Safe handling of hazardous chemotherapy drugs in limited-resource settings]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Washington DC, USA ]]></publisher-loc>
<publisher-name><![CDATA[PAHO/WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<collab>Instituto Nacional de Seguridad y Salud en el Trabajo (INSST)</collab>
<source><![CDATA[INFOMED -Información para trabajadores sanitarios sobre medicamentos peligrosos (Internet)]]></source>
<year></year>
<publisher-loc><![CDATA[Madrid, España ]]></publisher-loc>
<publisher-name><![CDATA[INSST]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[de Jong]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Pawlowska-Cyprysiak]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Hildt-Ciupinska]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Bos]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Nicolescu]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Trifu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Current and emerging occupational safety and health (OSH) issues in the healthcare sector, including home and community care: European Risk Observatory Report]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Luxembourg ]]></publisher-loc>
<publisher-name><![CDATA[European Union Publications Office]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<source><![CDATA[Prevention of Hazardous Drug Vapor Release by the Tevadaptor(r) Vial Adaptor]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Bethlehem, USA ]]></publisher-loc>
<publisher-name><![CDATA[B Braun Medical Inc]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<source><![CDATA[MAUDE - Manufacturer and User Facility Device Experience (Internet)]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Silver Spring, USA ]]></publisher-loc>
<publisher-name><![CDATA[U.S. Food and Drug Administration]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Radwick]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[5 Challenges of Closed System Transfer Devices (Internet)]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Bethesda, USA ]]></publisher-loc>
<publisher-name><![CDATA[Parenteral Drug Association]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casaus Lara]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<source><![CDATA[Guía de buenas prácticas de preparación de medicamentos en servicios de farmacia hospitalaria (Internet)]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Madrid, España ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Sanidad, Servicios Sociales e Igualdad]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García Salom]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[López Briz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Moya Gil]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ferriols Lisart]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Marco Garbayo]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Vila Clérigues]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<source><![CDATA[Guía para la adaptación de las buenas prácticas en la preparación y manipulación de medicamentos en la Comunidad Valenciana - Instalaciones (Internet)]]></source>
<year></year>
<publisher-loc><![CDATA[Valencia, España ]]></publisher-loc>
<publisher-name><![CDATA[Generalitat Valenciana]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García Salom]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[López Briz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Moya Gil]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ferriols Lisart]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Marco Garbayo]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Vila Clérigues]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<source><![CDATA[Guía para la adaptación de las Buenas Practicas en la Preparación y manipulación de Medicamentos en la Comunidad Valenciana - Equipamiento (Internet)]]></source>
<year></year>
<publisher-loc><![CDATA[Valencia, España ]]></publisher-loc>
<publisher-name><![CDATA[Generalitat Valenciana]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García Salom]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[López Briz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Moya Gil]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ferriols Lisart]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Marco Garbayo]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Gaspar Carreño]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Guía para la adaptación de las buenas prácticas en la preparación y manipulación de medicamentos en los servicios de farmacia en la Comunidad Valenciana - Procedimientos (Internet)]]></source>
<year></year>
<publisher-loc><![CDATA[Valencia, España ]]></publisher-loc>
<publisher-name><![CDATA[Generalitat Valenciana]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="">
<source><![CDATA[USP -800- Hazardous Drugs - Handling in Healthcare Settings Gap Analysis Survey]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="book">
<collab>Hazardous Drug Consensus Group</collab>
<source><![CDATA[Consensus Statement on the Handling of Hazardous Drugs Per USP Chapter -800-]]></source>
<year>2017</year>
<publisher-loc><![CDATA[USA ]]></publisher-loc>
<publisher-name><![CDATA[Accreditation Commission for Health Care]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
